Editorial Comment: 68Ga-Prostate-specific membrane antigen (PSMA) positron emission tomography (pet) in prostate cancer: a systematic review and meta-analysis
- PMID: 33848065
- PMCID: PMC8321502
- DOI: 10.1590/S1677-5538.IBJU.2019.0817.1
Editorial Comment: 68Ga-Prostate-specific membrane antigen (PSMA) positron emission tomography (pet) in prostate cancer: a systematic review and meta-analysis
Conflict of interest statement
None declared.
Comment on
-
68Ga-Prostate-specific membrane antigen (psma) positron emission tomography (pet) in prostate cancer: a systematic review and meta-analysis.Int Braz J Urol. 2021 Jul-Aug;47(4):705-729. doi: 10.1590/S1677-5538.IBJU.2019.0817. Int Braz J Urol. 2021. PMID: 33566470 Free PMC article.
References
-
- 2. Roach M 3rd, Hanks G, Thames H Jr, Schellhammer P, Shipley WU, Sokol GH, et al. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys. 2006;65:965-74. - PubMed
-
- 3. Ribeiro AMB, Lima ENP, Zequi SC. Evaluation of the clinical use of PET/CT with 68Ga-PSMA for the assessment of biochemical recurrence of low or intermediate-risk prostate cancer. Urol Oncol. 2021;39:73.e9-73.e18. - PubMed
-
- 5. Maurer T, Graefen M, van der Poel H, Hamdy F, Briganti A, Eiber M, et al. Prostate-Specific Membrane Antigen-Guided Surgery. J Nucl Med. 2020;61:6-12. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous